Head and Neck Tumor Surgery: diagnosis, function and long-term planning
Head and Neck Tumor Surgery is considered when a head or neck tumor is resectable and surgery offers appropriate cancer control with an acceptable functional plan.
Tumor site, HPV or EBV context, stage, nodal disease, prior radiation and the expected speech, swallowing and appearance consequences determine whether surgery, radiation, systemic therapy or combined care is preferred.
Who may be considered?
Specialist review may help when biopsy confirms or strongly suggests a tumor requiring multidisciplinary cancer treatment.
- Resectable oral, throat, laryngeal, salivary or sinonasal cancer.
- A persistent or recurrent tumor after prior treatment.
- Selected benign but locally destructive tumors.
- A patient with a complete reconstruction and rehabilitation plan.
What the specialist team must confirm
Review pathology and biomarkers, contrast CT or MRI, PET-CT when indicated, endoscopy, dental status, nutrition, airway, speech and swallow baseline, nodal staging and prior radiation or chemotherapy.
Key points for this treatment
From biopsy staging to cancer control and functional rehabilitation
The pathway should anticipate pathology findings that change radiation, systemic therapy or rehabilitation.
Recovery integrates wound healing, nutrition and communication
Airway monitoring, pain control, flap or wound checks, nutrition and early speech and swallowing input are central after major surgery.
Surveillance looks for recurrence and second cancers while dental, shoulder, thyroid, speech, swallowing and psychosocial effects are managed.
Risks, limits and realistic expectations
Risks include bleeding, infection, fistula, airway problems, nerve injury, shoulder weakness, speech or swallowing loss, flap failure, appearance change, recurrence and treatment-related complications.
Breathing difficulty, neck swelling, heavy bleeding, flap color change, saliva leaking through the wound, fever or inability to manage secretions needs emergency care.